Cytokinetics Inc (CYTK)
66.24
-0.11
(-0.17%)
USD |
NASDAQ |
Apr 23, 14:57
Cytokinetics Total Assets (Quarterly): 824.32M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 824.32M |
| September 30, 2023 | 740.61M |
| June 30, 2023 | 779.90M |
| March 31, 2023 | 889.82M |
| December 31, 2022 | 1.015B |
| September 30, 2022 | 1.076B |
| June 30, 2022 | 771.72M |
| March 31, 2022 | 856.25M |
| December 31, 2021 | 841.32M |
| September 30, 2021 | 827.54M |
| June 30, 2021 | 564.30M |
| March 31, 2021 | 577.06M |
| December 31, 2020 | 533.80M |
| September 30, 2020 | 474.11M |
| June 30, 2020 | 232.50M |
| March 31, 2020 | 256.58M |
| December 31, 2019 | 289.81M |
| September 30, 2019 | 187.39M |
| June 30, 2019 | 198.22M |
| March 31, 2019 | 198.61M |
| December 31, 2018 | 211.18M |
| September 30, 2018 | 230.28M |
| June 30, 2018 | 247.24M |
| March 31, 2018 | 279.93M |
| December 31, 2017 | 294.81M |
| Date | Value |
|---|---|
| September 30, 2017 | 326.31M |
| June 30, 2017 | 340.63M |
| March 31, 2017 | 265.37M |
| December 31, 2016 | 170.14M |
| September 30, 2016 | 158.17M |
| June 30, 2016 | 106.16M |
| March 31, 2016 | 113.22M |
| December 31, 2015 | 115.24M |
| September 30, 2015 | 102.20M |
| June 30, 2015 | 112.71M |
| March 31, 2015 | 122.21M |
| December 31, 2014 | 132.97M |
| September 30, 2014 | 87.18M |
| June 30, 2014 | 96.14M |
| March 31, 2014 | 107.28M |
| December 31, 2013 | 83.19M |
| September 30, 2013 | 88.01M |
| June 30, 2013 | 94.56M |
| March 31, 2013 | 64.69M |
| December 31, 2012 | 77.55M |
| September 30, 2012 | 85.34M |
| June 30, 2012 | 94.08M |
| March 31, 2012 | 46.53M |
| December 31, 2011 | 52.77M |
| September 30, 2011 | 61.78M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
187.39M
Minimum
Sep 2019
1.076B
Maximum
Sep 2022
628.21M
Average
740.61M
Median
Sep 2023
Total Assets (Quarterly) Benchmarks
| Amgen Inc | 97.15B |
| Johnson & Johnson | 167.56B |
| Eli Lilly and Co | 64.01B |
| Viking Therapeutics Inc | 368.49M |
| Madrigal Pharmaceuticals Inc | 640.55M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.211B |
| Shareholders Equity (Quarterly) | -386.32M |
| Debt to Equity Ratio | -1.598 |
| Current Ratio | 6.117 |
| Net Debt Paydown Yield | -0.02% |